Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Odronextamab plus chemotherapy in patients with previously untreated follicular lymphoma: First results from part 1 of the Phase 3 Olympia-2 study

Kitsada Wudhikarn, Tuba Hacibekiroglu, Jose Angel Hernandez Rivas, Sebastian Grosicki, Jingxian Cai, Jingxiao Chen, Jurriaan Brouwer-Visser, Julia Held, Aafia Chaudhry, Hesham Mohamed, Ashish Risal, Aránzazu Alonso Alonso

Blood (2025) 146 (Supplement 1): 3600.

https://doi.org/10.1182/blood-2025-3600

Published: 2025

Journal Articles

Odronextamab plus chemotherapy in patients with previously untreated diffuse large B-cell lymphoma (DLBCL): First Results from part 1 of the Phase 3 Olympia-3 study

Jean-Marie Michot, Munci Yagci, Katherine Kargus, Hesham Mohamed, Jingxiao Chen, Jurriaan Brouwer-Visser, Aafia Chaudhry, Nazia Iqbal, Matthew Matasar

Blood (2025) 146 (Supplement 1): 65.

https://doi.org/10.1182/blood-2025-65

Published: 2025

Journal Articles

Odronextamab (Odro) plus lenalidomide (+Len) in patients with relapsed/refractory (R/R) follicular lymphoma (FL): First results from part 1 (safety lead-in) of the Phase 3 OLYMPIA-5 study

Umberto Vitolo, Lalita Norasetthada, Jae-Cheol Jo, Biyi Shen, Dina Flink, Min Zhu, Soujanya Chandrasekharan, Jingxiao Chen, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Sabela Bobillo-Varela, Catherine Thieblemont

Blood (2025) 146 (Supplement 1): 5381.

https://doi.org/10.1182/blood-2025-5381

Published: 2025